The 86th Annual Meeting of the Japanese Cancer Association【Osaka Prefecture】
The 86th Annual Meeting of the Japanese Cancer Association (JCA2027) will take place September 16–18, 2027, at the Osaka International Convention Center and NCB Hall in Osaka, Japan. The meeting theme is “Pioneering Future Strategies for Cancer Control through Collaborative Innovation.” The meeting president is Dr. Naoko Ohtani of Osaka Metropolitan University Graduate School of Medicine. The meeting covers cancer research from fundamental science to prevention, diagnosis, treatment and drug discovery. Planned scientific topics include spatial and spatiotemporal cancer research, the tumor microenvironment, next-generation antibody therapeutics, cancer genomics and cancer immunotherapy, with an emphasis on collaboration among basic scientists, clinical researchers and industry.
Meeting Theme and Objectives
Pioneering Future Strategies for Cancer Control through Collaborative Innovation
Japanese theme: 協創力で拓くがん制御への未来戦略
Despite advances in understanding the molecular mechanisms of cancer development and progression and in developing targeted therapies, further research is needed to achieve effective cancer control. The meeting aims to develop new strategies through interdisciplinary cooperation, partnerships among fundamental research, clinical medicine and industry, collaboration across generations of researchers, and international scientific exchange.
The meeting provides a forum for sharing developments in translational research, emerging drug discovery technologies, cancer prevention and early detection, connecting basic scientific discoveries with diagnostic and therapeutic applications.
Official information: Welcome Message
86th Annual Meeting of the Japanese Cancer Association: Event Information
- Official English Name: The 86th Annual Meeting of the Japanese Cancer Association
- Official Japanese Name: 第86回日本癌学会学術総会
- Dates: September 16–18, 2027 (Thursday–Saturday)
- Venues: Osaka International Convention Center (Grand Cube Osaka) and NCB Hall
- Location: Nakanoshima, Kita-ku, Osaka, Japan
- Organizer: Japanese Cancer Association (JCA)
- Meeting Theme: Pioneering Future Strategies for Cancer Control through Collaborative Innovation
- Meeting Format: Physical venues have been announced. Online streaming and hybrid participation arrangements have not been confirmed.
Official information: General Information (English) / Japanese Cancer Association Annual Meeting Schedule (Japanese)
Meeting Organization
Meeting President: Dr. Naoko Ohtani
Professor, Osaka Metropolitan University Graduate School of Medicine, specializing in pathophysiology.
- General Affairs Committee Lead: Dr. Kenichi Kohashi (Osaka Metropolitan University)
- Finance Committee Lead: Dr. Hirohisa Nakamae (Osaka Metropolitan University)
- Scientific Affairs, Basic Research: Dr. Takashi Kohno (National Cancer Center)
- Scientific Affairs, Clinical Research: Dr. Seiji Yano (Kanazawa University)
- Congress Secretariat: Convention Linkage, Inc.
- Address: PIAS TOWER 11F, 3-19-3 Toyosaki, Kita-ku, Osaka 531-0072, Japan
- Tel: +81-6-6377-2188
- Fax: +81-6-6377-2075
- Email: jca2027@c-linkage.co.jp
Further details of the organizing committee and core program committee are available on the official meeting website.
Official information: Organizing Committee (Japanese)
Key Research Areas and Highlights
The following research areas reflect the planned scientific topics announced on the official call for symposium proposals page.
- Spatial Biology and Spatial Omics: Spatial and spatiotemporal approaches to cancer research, spatial profiling of clinical specimens, and analysis of cellular distributions and interactions within tumor tissues.
- Tumor Microenvironment (TME): Cancer metabolism, immune and stromal cells surrounding tumors, and therapeutic approaches targeting the tumor microenvironment.
- Cancer Immunotherapy: Emerging antitumor immune strategies, cancer antigens, immune activation, cellular therapies and response prediction for immune checkpoint inhibitor (ICI) treatment.
- Cancer Genomics and Epigenomics: Large-scale clinical genomic datasets, next-generation cancer genomics, hereditary tumors and epigenomic regulation.
- Drug Discovery and Next-Generation Antibody Therapeutics: Novel drug target identification, antibody therapeutics, drug discovery technologies and the integration of basic biology with medicinal chemistry.
- Patient-Derived Cancer Models: Prediction of therapeutic responses and evaluation of drug sensitivity using patient-derived experimental models.
- Treatment Resistance, Metastasis and Recurrence: Cell death, cancer cell dormancy, minimal residual disease (MRD), and mechanisms of metastasis and recurrence.
- Artificial Intelligence and Data Science: AI-enabled cancer research, diagnostic technologies and clinical data analysis.
Pharma Nexus highlights: Particularly relevant technologies include spatial proteomics, multiplex immunofluorescence, spatial transcriptomics, digital pathology, single-cell analysis, organoids, flow cytometry, cell culture and drug discovery screening. Research integrating the spatial organization of tumor tissues with cellular composition and cell-cell interactions may support therapeutic response prediction and the identification of new treatment targets. These are related technology areas identified by Pharma Nexus, not confirmed product exhibitions or technology selections at the meeting.
Official information: Planned Symposia and Workshops (Japanese)
Call for Abstracts and Symposium Proposals
As of November 13, 2026, the meeting is accepting symposium proposals from JCA members. This is separate from the call for general scientific abstracts.
- Symposium Proposal Submission Period: October 15–November 17, 2026 (Thursday–Tuesday).
- Eligibility: JCA members without conflicts of interest involving tobacco-related organizations.
- Organizer: The proposer must submit the proposal and also serve as a session chair.
- Session Chairs: Normally two chairs. Nonmembers may serve as co-chairs.
- Presentation Language: Japanese or English. Abstracts for accepted symposia must be prepared in English, even when the presentations are in Japanese.
- Proposal Selection: The program committee will review the scientific content and determine acceptance.
- General Abstract Submissions: Submission dates, eligibility and abstract requirements are under preparation.
The call encourages original symposium proposals exploring topics not sufficiently covered by the planned meeting program, new perspectives from early-career researchers, interdisciplinary collaborations and emerging research fields. Applicants should consult the official submission guidelines and planned scientific topics.
Official information: Call for Symposium Proposals and Submission Forms (Japanese)
Scientific Program and Schedule
The detailed scientific timetable is under preparation. However, the official call for symposium proposals page has announced major topics for planned symposia and workshops.
Selected Planned Meeting Symposia Topics
- AI applications in cancer research and large-scale genomic data analysis.
- Spatial and spatiotemporal analysis, cancer metabolism and the tumor microenvironment.
- Next-generation antibody therapeutics, antitumor immunity, novel drug targets and discovery technologies.
- Pancreatic cancer, liver cancer, hematologic malignancies, and pediatric and adolescent and young adult (AYA) cancers.
- The microbiome, aging, cancer prevention and hereditary tumors.
Selected Planned Inter-Society and Multidisciplinary Symposia Topics
- Next-generation cancer immunotherapy and cell therapy, cancer antigens and immune activation.
- RNA biology, the dark transcriptome and cancer neuroscience.
- Tumor microenvironment stiffness and cancer progression, theranostics, comparative biology, and exercise-based cancer prevention.
Selected Planned Workshops Bridging Basic and Clinical Research
- Assessment of minimal residual disease and prediction of cancer recurrence.
- Predictive biomarkers and patient stratification for ICI treatment.
- AI-based diagnosis, cancer cachexia and spatial analysis of clinical specimens.
- Prediction of therapeutic responses using patient-derived cancer models.
- New drug discovery approaches connecting biology and medicinal chemistry.
These are English summaries of planned scientific topics announced by the organizers. Confirm speakers, official session titles, presentation times and venue assignments in forthcoming program updates.
Official information: Planned Scientific Topics (Japanese) / Official Meeting Website and Updates (English)
Registration and Fees
As of November 13, 2026, registration dates and participation fees for the 86th annual meeting have not been confirmed. The official meeting website includes a registration information section, with further details to be announced.
- Registration Opening Date: Under preparation.
- Advance Registration Deadline: Under preparation.
- Registration Fees and Categories: Under preparation.
- Student and Nonmember Participation Requirements: Details not confirmed.
- Online Participation, Accreditation Credits and Accommodation: Details not confirmed.
- Travel Grants and Visa Information for International Participants: Consult forthcoming announcements on the official English website.
Registration fees and schedules from the 2026 meeting have not been applied to the 2027 meeting.
Official information: Registration and Latest Meeting Information (English)
Corporate Sponsorship and Exhibition Opportunities (Applications Open)
The 86th Annual Meeting of the Japanese Cancer Association is accepting applications for sponsored seminars, corporate and book exhibitions, advertising and donations. Exhibition opportunities include standard booths, space-only booths, pitch presentations and access to research consultation rooms, subject to the official sponsorship arrangements.
- Luncheon, Morning and Coffee Break Seminars: Application deadline April 16, 2027 (Friday).
- Corporate and Book Exhibitions: Application deadline June 18, 2027 (Friday).
- Program Book Advertising: Application deadline June 18, 2027 (Friday).
- Website and Electronic Abstract App Banner Advertising: Application deadline July 16, 2027 (Friday).
- Venue Signage and Intermission Commercial Advertising: Application deadline July 16, 2027 (Friday).
- Poster Panel Pin Container Advertising, Name Badge Lanyards and Congress Bags: Application deadline August 6, 2027 (Friday).
- Donations: Application deadline September 15, 2027 (Wednesday).
Application Procedure: Submit applications online using the sponsorship application system linked from the official sponsorship page. Applications may close early if available allocations are filled. Consult the official sponsorship prospectus for pricing, booth specifications, application requirements and cancellation terms.
Pharma Nexus highlights: The meeting is relevant to companies supplying cancer research instruments, antibodies and immunostaining reagents, spatial omics technologies, molecular diagnostics, genomic analysis, cell culture, drug discovery services and image analysis. Companies can consider combining exhibitions, sponsored seminars and pitch presentations to communicate technologies relevant to the scientific program and researchers’ needs.
Sponsorship Secretariat: Convention Linkage, Inc. / Email: jca2027@c-linkage.co.jp
Official information: Sponsorship Opportunities and Online Application System (Japanese)
Venues and Access
Osaka International Convention Center (Grand Cube Osaka)
5-3-51 Nakanoshima, Kita-ku, Osaka 530-0005, Japan
- Immediately outside Exit 2 of Nakanoshima Station on the Keihan Nakanoshima Line.
- Approximately 10 minutes on foot from Shin-Fukushima Station on the JR Tozai Line.
- Approximately 15 minutes on foot from Fukushima Station on the JR Osaka Loop Line.
NCB Hall
6-2-27 Nakanoshima, Kita-ku, Osaka 530-6691, Japan
- Approximately 4 minutes on foot from Exit 2 of Nakanoshima Station on the Keihan Nakanoshima Line.
- Approximately 8 minutes on foot from Exit 9 of Awaza Station on Osaka Metro.
The meeting will use two venues. Participants should check venue assignments for scientific sessions and exhibitions in advance. Consult the official meeting venue guide for lecture rooms, registration areas and exhibition locations once published. Walking times are estimates provided by the respective venues.
Official information: Osaka International Convention Center Access Guide (Japanese) / Nakanoshima Center Building Access Information (Japanese)
Official Websites
86th JCA Annual Meeting Official Website (English)
Official Meeting Website (Japanese)
Organizing Committee (Japanese)
Call for Symposium Proposals and Planned Scientific Topics (Japanese)
Sponsorship and Exhibition Opportunities (Japanese)
Japanese Cancer Association Annual Meeting Schedule
Osaka International Convention Center Access Guide (Japanese)
NCB Hall Access Information (Japanese)
Information checked November 13, 2026. Meeting information, the official theme, planned scientific topics and sponsorship deadlines are based on official announcements. Scientific programs, abstract submissions, registration and exhibition requirements are subject to change. Please consult the official meeting website for the latest information.
